Pancreatic Cancer
Pancreatic Cancer
Advertisement
Zachary BessettePancreatic Cancer | February 14, 2024
The NAPOLI 3 study demonstrated improved OS and PFS in patients with metastatic pancreatic cancer and no prior chemotherapy.
Read More
Emily MenendezPancreatic Cancer | February 13, 2024
Future trials for resectable pancreatic ductal adenocarcinoma should be driven by patient biomarkers.
Katy MarshallPancreatic Cancer | February 6, 2024
The ELI-002 vaccine uses T cells to identify and remove tumor cells containing KRAS G12D- or G12R-mutated cancer.
Kawther Abdilleh, PhDPancreatic Cancer | January 29, 2024
Dr. Abdilleh discusses PanCAN's new cloud-based data and analytics program for pancreatic cancer research.
Ethan Ludmir, MDASCO GI 2024 | January 25, 2024
Dr. Ethan Ludmir discusses the phase II EXTEND trial on MDT with systemic therapy for pancreatic ductal adenocarcinoma.
Katy MarshallASCO GI 2024 | January 23, 2024
A subanalysis of the GENESECT study analyzed data from 50 gemcitabine monotherapy patients.
Zachary BessetteASCO GI 2024 | January 23, 2024
A recent study sought to better understand the association between EPI and development of pancreatic cancer.
Katy MarshallPancreatic Cancer | January 23, 2024
The study evaluated the cost-effectiveness of combined MRI and EUS screening for populations at high risk for PDAC.
Dr. Harmeet DhaniPancreatic Cancer | January 23, 2024
Dr. Harmeet Dhani highlights new research on the benefits of liquid biopsies for patients with pancreatic cancer.
Katy MarshallPancreatic Cancer | November 17, 2023
Researchers performed a 2-sample Mendelian randomization analysis conducted at the genus level.
Katy MarshallPancreatic Cancer | November 3, 2023
Participating patients received PERT at baseline or within 3 months of receiving first-line treatment.
Rebecca AraujoPancreatic Cancer | September 8, 2023
Nimotuzumab plus gemcitabine demonstrated a favorable safety profile in patients with metastatic pancreatic cancer.
Rob DillardPancreatic Cancer | August 31, 2023
Results from a recent study suggest a novel therapy that may effectively treat pancreatic ductal adenocarcinoma.
Cailin ConnerPancreatic Cancer | August 22, 2023
According to a recent study larger hospital volume is linked with better pancreatic cancer treatment outcomes.
Rob DillardPancreatic Cancer | August 22, 2023
Performing minimally invasive surgery on patients with newly diagnosed pancreatic cancer helps identify disease spread.
Rob DillardADA 2023 | August 22, 2023
A study sought to differentiate between diabetes due to pancreatic cancer and type 2 diabetes.
Patrick DalyPancreatic Cancer | August 22, 2023
In a recent study, researchers investigated the value of serum exosomal and serum glypican 1 (GPC-1) in predicting ...
Patrick DalyPancreatic Cancer | August 22, 2023
In a phase 1b trial, researchers evaluated the safety and efficacy profiles of combined S-1, irinotecan, and oxaliplatin ...
Patrick DalyPancreatic Cancer | August 22, 2023
According to Dirk Weyhe and collaborating researchers, patients experience significantly reduced physical and ...
DocWire News EditorsPancreatic Cancer | August 22, 2023
Anticancer Res. 2022 May;42(5):2425-2432. doi: 10.21873/anticanres.15721.ABSTRACTBACKGROUND: Pancreatic cancer is the ...
Advertisement
Advertisement
Advertisement
Latest News

February 28, 2024